Health ❯ Clinical Trials

Phase 1 Trials

Safety and Efficacy Animal Models Patient Recruitment Drug Mechanism Vaccine Development Vaccine Safety Oncology Trials Weight Loss Medications Drug Development Chronic Weight Management Drug Testing Gene Therapy Trials Patient Monitoring DREAMM-9 Trial

Pfizer Licenses Early-Stage Oral GLP-1 From YaoPharma in Up to $2 Billion Deal

The deal brings an oral obesity candidate into Pfizer’s pipeline, with YaoPharma finishing Phase 1 in Australia before a planned handoff.

Janux Plunges on Mixed Phase 1 Prostate Cancer Data for JANX007

Single-Infusion CRISPR Therapy Lowers LDL and Triglycerides in First Human Trial

Sanofi Signs $1.15 Billion Deal to Acquire Vicebio’s Molecular Clamp Respiratory Vaccine Platform

Engineered Gut Microbe for Kidney Stones Gets Triple Safeguard After Mutation Concerns